Succinylcholine for emergency airway rescue in class b ambulatory facilities: The society for ambulatory anesthesia position statement

Girish P. Joshi, Meena S. Desai, Steven Gayer, Hector Vila

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedativehypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine- triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.

Original languageEnglish (US)
Pages (from-to)1447-1449
Number of pages3
JournalAnesthesia and Analgesia
Volume124
Issue number5
DOIs
StatePublished - 2017

Fingerprint

Succinylcholine
Emergencies
Anesthesia
Malignant Hyperthermia
Laryngismus
Dantrolene
Airway Management
Analgesics
Anesthetics
Morbidity
Mortality

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Succinylcholine for emergency airway rescue in class b ambulatory facilities : The society for ambulatory anesthesia position statement. / Joshi, Girish P.; Desai, Meena S.; Gayer, Steven; Vila, Hector.

In: Anesthesia and Analgesia, Vol. 124, No. 5, 2017, p. 1447-1449.

Research output: Contribution to journalArticle

@article{1b89d5c2057b4b2791ccb64c5d20ab2b,
title = "Succinylcholine for emergency airway rescue in class b ambulatory facilities: The society for ambulatory anesthesia position statement",
abstract = "Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedativehypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine- triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.",
author = "Joshi, {Girish P.} and Desai, {Meena S.} and Steven Gayer and Hector Vila",
year = "2017",
doi = "10.1213/ANE.0000000000001682",
language = "English (US)",
volume = "124",
pages = "1447--1449",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Succinylcholine for emergency airway rescue in class b ambulatory facilities

T2 - The society for ambulatory anesthesia position statement

AU - Joshi, Girish P.

AU - Desai, Meena S.

AU - Gayer, Steven

AU - Vila, Hector

PY - 2017

Y1 - 2017

N2 - Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedativehypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine- triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.

AB - Procedures in class B ambulatory facilities are performed exclusively with oral or IV sedativehypnotics and/or analgesics. These facilities typically do not stock dantrolene because no known triggers of malignant hyperthermia (ie, inhaled anesthetics and succinylcholine) are available. This article argues that, in the absence of succinylcholine, the morbidity and mortality from laryngospasm can be significant, indeed, higher than the unlikely scenario of succinylcholine- triggered malignant hyperthermia. The Society for Ambulatory Anesthesia (SAMBA) position statement for the use of succinylcholine for emergency airway management is presented.

UR - http://www.scopus.com/inward/record.url?scp=85018334497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018334497&partnerID=8YFLogxK

U2 - 10.1213/ANE.0000000000001682

DO - 10.1213/ANE.0000000000001682

M3 - Article

C2 - 27984222

AN - SCOPUS:85018334497

VL - 124

SP - 1447

EP - 1449

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 5

ER -